PDS Biotechnology Corporation

PDSB·NASDAQ·$1.10Share Price as of 11/2·$61MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/14/26 10-K/AFY 202504/28/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/13/25

Disclosures

8-KCurrent report10/21/26 8-KCurrent report10/20/26 8-KCurrent report10/06/26 8-KCurrent report09/22/26 8-KCurrent report09/21/26

Prospectuses and Registrations

S-3Shelf registration10/14/26 424B4Prospectus07/21/26 S-3Shelf registration07/10/26 424B5Prospectus supplement06/15/26 S-3/AShelf registration (amended)04/24/26

Proxies

DEF 14ADefinitive proxy06/26/26 DEFA14AAdditional proxy materials06/26/26 PRE 14APreliminary proxy06/15/26 DEFR14ADefinitive proxy (revised)05/22/25 DEFR14ADefinitive proxy (revised)05/05/25

Ownership

Form 3Initial insider ownership10/21/26 Form 4Insider transaction10/21/26 Form 3Initial insider ownership10/20/26 Form 3Initial insider ownership10/20/26 Form 4Insider transaction10/20/26

Other

EFFECTRequest for effectiveness07/21/26 ARSAnnual report to shareholders06/26/26 EFFECTRequest for effectiveness04/28/26 CORRESPCorrespondence with the SEC04/24/26 UPLOADLetter from the SEC09/04/25